Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,42 HKD | +1,43% | +4,41% | -2,74% |
03/04 | Ascletis staakt proeven met FXR-agonisten voor galwegcholangitis, NASH en hepatitis B-virus | MT |
03/04 | Ascletis Pharma Inc. kondigt strategische beslissingen aan over FXR-agonist ASC42 | CI |
Vakgebied
Aantal werknemers: 219
Verkoop per activiteit
HKD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100,0
%
| 63 | 100,0 % | 63 | 100,0 % | -0,57% |
Verkoop per regio
HKD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
China
100,0
%
| 63 | 100,0 % | 63 | 100,0 % | -0,53% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jinzi Wu
CEO | Chief Executive Officer | 61 | - |
Yan Yuemei
CTO | Chief Tech/Sci/R&D Officer | - | - |
Handan He
CTO | Chief Tech/Sci/R&D Officer | - | 07-10-19 |
Zhengqing Li
CTO | Chief Tech/Sci/R&D Officer | - | 28-02-19 |
Chief Operating Officer | 50 | 13-03-19 | |
Joshua Zhongbao
PRN | Corporate Officer/Principal | - | 30-08-18 |
Ming Fai Chung
SEC | Corporate Secretary | 45 | 22-08-22 |
John Gargiulo
PRN | Corporate Officer/Principal | - | 12-06-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jinzi Wu
CEO | Chief Executive Officer | 61 | - |
Jiong Gu
BRD | Director/Board Member | 51 | 01-04-18 |
Chief Operating Officer | 50 | 13-03-19 | |
Yizhen Wei
BRD | Director/Board Member | 49 | 27-04-18 |
Lin Hua
BRD | Director/Board Member | 50 | 27-04-18 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 1 012 758 000 | 286 381 323 ( 28,28 %) | 0 | 28,28 % |
Bedrijfsgegevens
Ascletis Pharma, Inc.
HIPARK, 198 Qidi Road Xiaoshan District
311200, Hangzhou
+86 571 8538 9730
http://www.ascletis.comSector
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-2,74% | 181 mln. | |
-3,79% | 87,06 mld. | |
+1,45% | 40,25 mld. | |
-16,46% | 31,09 mld. | |
+52,66% | 24,74 mld. | |
-14,08% | 15,91 mld. | |
-9,12% | 11,96 mld. | |
-15,05% | 11,92 mld. | |
-42,56% | 11,61 mld. | |
+4,87% | 8,73 mld. |
- Beurs
- Aandelen
- Koers 1672
- Onderneming Ascletis Pharma Inc.